2013
DOI: 10.1007/s00044-013-0890-z
|View full text |Cite
|
Sign up to set email alerts
|

Synthesis of 5-arylidine amino-1,3,4-thiadiazol-2-[(N-substituted benzyol)]sulphonamides endowed with potent antioxidants and anticancer activity induces growth inhibition in HEK293, BT474 and NCI-H226 cells

Abstract: A series of imines 5-amino-1,3,4-thiadiazol-2-[(N-substituted benzyol)]sulphonamide derivatives were synthesized from various aromatic aldehydes and substituted with benzoyl acetazolamides under different reaction conditions and were evaluated for their antioxidant and free radical scavenging, antimitotic activity by Allium cepa meristem root model and cytotoxicity activity against HEK 293 (human epidermal kidney cell line), BT474 (breast cancer cell line) and NCI-H226 (lung cancer cell line) by MTT assay. Som… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
14
0

Year Published

2015
2015
2023
2023

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 17 publications
(14 citation statements)
references
References 62 publications
0
14
0
Order By: Relevance
“…The most active compounds are: N -({5-[(2-methoxybenzylidene)amino]-1,3,4-thiadiazol-2-yl}sulfonyl)benzamide 28 (CTC 50 = 0.794 µM against breast cancer cell line, CTC 50 —concentration required to reduce viability by 50%) and N -({5-[(furan-2-ylmethylidene)amino]-1,3,4-thiadiazol-2-yl}sulfonyl)benzamide 29 (CTC 50 = 0.913 µM against lung cancer cell line) ( Figure 14 ). None of the tested compounds were found to be as potent as the reference drug [ 24 ].…”
Section: Derivatives Of 25-disubstituted-134-thiadiazolementioning
confidence: 99%
“…The most active compounds are: N -({5-[(2-methoxybenzylidene)amino]-1,3,4-thiadiazol-2-yl}sulfonyl)benzamide 28 (CTC 50 = 0.794 µM against breast cancer cell line, CTC 50 —concentration required to reduce viability by 50%) and N -({5-[(furan-2-ylmethylidene)amino]-1,3,4-thiadiazol-2-yl}sulfonyl)benzamide 29 (CTC 50 = 0.913 µM against lung cancer cell line) ( Figure 14 ). None of the tested compounds were found to be as potent as the reference drug [ 24 ].…”
Section: Derivatives Of 25-disubstituted-134-thiadiazolementioning
confidence: 99%
“…Unregulated or over-expressed matrix metalloproteinases (MMPs), including stromelysin, collagenase and gelatinase, were implicated in several pathological conditions, including arthritis and cancer. The 1,3,4-thiadozole compounds have been reported to inhibit selectively fibroblast stromelysin-1 [ 24 , 29 ]. In order to predict the binding affinity of our newly synthesized N -((5-(substituted methylene amino)-1,3,4-thiadiazol-2-yl)methyl) benzamide 7 ( a – l ) derivatives into the binding site of fibroblast stromelysin-1, we decided to carry out a molecular docking study.…”
Section: Resultsmentioning
confidence: 99%
“…Especially, the structure of ‘‘N–C–S’’ in 1,3,4-thiadiazole derivatives can work as the active center, chelate certain metal ions in vivo and show good tissue permeability. The synthesis of novel thiadiazole derivatives and investigation of their chemical and biological behavior have gained more importance in recent decades [ 21 , 22 , 23 , 24 ]. The 1,3,4-thiadozole compounds have been reported to inhibit MMPs [ 25 ].…”
Section: Introductionmentioning
confidence: 99%
“…Again, HeLa cells were more susceptible to the cytotoxicity of Cu-4pyr.Trp than KCL-22 cells ( Figure 5, B ). Earlier, several Schiff bases were tested in vitro for their cytotoxic activity against different cell lines and the structure activity relationship of compounds was discussed 17 , 31 , 32 . Furthermore, Kril et al .…”
Section: Resultsmentioning
confidence: 99%